Pharmabiz12h
Harbour BioMed announces license agreement with Windward Bio for HBM9378/SKB378, an anti-TSLP fully human antibody for immunological diseases
Cambridge, Massachusetts Monday, January 13, 2025, 13:30 Hrs [IST] ...
Pharmabiz16h
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi: Our Bureau, Bengaluru Monday, January 13, 2025, 09:00 Hrs [IST] The Authentic ...
Pharmabiz13h
AIG Group of Hospitals in Hyderabad to invest Rs. 800 crore in Proton Beam Therapy to treat complex cancers
AIG Group of Hospitals in Hyderabad to invest Rs. 800 crore in Proton Beam Therapy to treat complex cancers: Our Bureau, Chennai Monday, January 13, 2025, 12:15 Hrs [IST] The Boar ...
Pharmabiz10h
ProMIS Neurosciences begins PRECISE-AD phase 1b trial of lead therapeutic candidate, PMN310 in Alzheimer’s disease
Cambridge, Massachusetts Monday, January 13, 2025, 15:00 Hrs [IST] ...
Pharmabiz12h
GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion
GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion: London, UK Monday, January 13, 2025, 13:35 Hrs [IST] GSK plc and IDRx, Inc. (IDRx) ann ...
Pharmabiz8h
Qiagen increases QIAcuity Digital PCR High-Order Multiplexing capabilities to gain deeper insights from biological samples
Venlo, Netherlands Monday, January 13, 2025, 17:00 Hrs [IST] ...
Pharmabiz9h
NIHR-funded research shows AI may help doctors improve the success rates of IVF treatment
NIHR-funded research shows AI may help doctors improve the success rates of IVF treatment: United Kingdom Monday, January 13, 2025, 16:00 Hrs [IST] NIHR-funded research has discov ...
Pharmabiz2d
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim and Synaffix B.V. (Synaffix), a Lonza company focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug conjugates (ADCs ...
Pharmabiz9h
Crinetics Pharma reports positive results from phase 2 trial of atumelnant in congenital adrenal hyperplasia
Crinetics Pharma reports positive results from phase 2 trial of atumelnant in congenital adrenal hyperplasia: San Diego Monday, January 13, 2025, 16:30 Hrs [IST] Crinetics Pharmac ...
Pharmabiz2d
Seven research leaders awarded prestigious NIHR award
The NIHR has announced the latest outstanding researchers to become NIHR Research Professors. They will play a key role in undertaking professorial-level research that has a positive impact on the ...
Pharmabiz2d
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market
Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the Middle East market – both for Gaelic Laboratories and its marketing partners ...
Pharmabiz11h
BioDuro opens new solid-phase peptide synthesis scale-up facility in China
BioDuro opens new solid-phase peptide synthesis scale-up facility in China: Irvine, California Monday, January 13, 2025, 14:30 Hrs [IST] BioDuro, a leading contract research, deve ...